Literature DB >> 17270086

Measurement of serum testosterone in women; what should we do?

John Kane1, Jonathan Middle, Marion Cawood.   

Abstract

All immunoassays for female serum testosterone give falsely high results in some samples. The effect is variable and cannot be predicted for any given sample. Inaccurate calibration or interference by cross-reacting substances is almost certainly the cause of the problem, but for many immunoassays, the exact nature of the interferent is not known. Some of the interference can be removed by employing an extraction step prior to immunoassay. The advent of fast simple and sensitive liquid chromatography tandem mass spectrometry methods offers an exciting alternative to immunoassay for serum testosterone measurement. It is recommended that all high serum testosterone concentrations in women are checked, before reporting, by a method which is accurate (i.e. minimal bias to isotope dilution gas chromatography mass spectrometry [ID-GCMS] method) and is not subject to interference. Action should also be taken by assay users, manufacturers, regulators and professional bodies to ensure accurate standardization and comparability of assays.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17270086     DOI: 10.1258/000456307779595896

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  7 in total

1.  First case report of testosterone assay-interference in a female taking maca (Lepidium meyenii).

Authors:  L Srikugan; A Sankaralingam; B McGowan
Journal:  BMJ Case Rep       Date:  2011-03-25

2.  LC-MS/MS detection of increased androstenedione levels in patients receiving danazol therapy.

Authors:  Verena Gounden; Diala El-Maouche; Brian R Stolze; Ranganath Muniyappa; Steven J Soldin
Journal:  Ther Drug Monit       Date:  2014-12       Impact factor: 3.681

3.  Validity of serum testosterone, free androgen index, and calculated free testosterone in women with suspected hyperandrogenism.

Authors:  Manal K Al Kindi; Faiza S Al Essry; Fatma S Al Essry; Waad-Allah S Mula-Abed
Journal:  Oman Med J       Date:  2012-11

4.  Prenatal Exposure to Perfluoroalkyl Acids and Serum Testosterone Concentrations at 15 Years of Age in Female ALSPAC Study Participants.

Authors:  Mildred Maisonet; Antonia M Calafat; Michele Marcus; Jouni J K Jaakkola; Hany Lashen
Journal:  Environ Health Perspect       Date:  2015-06-02       Impact factor: 9.031

Review 5.  Challenges and improvements in testosterone and estradiol testing.

Authors:  Hubert W Vesper; Julianne C Botelho; Yuesong Wang
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

6.  Does adding metformin to clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome?

Authors:  E Moll; J C Korevaar; P M M Bossuyt; F van der Veen
Journal:  Hum Reprod       Date:  2008-05-17       Impact factor: 6.918

7.  Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women.

Authors:  Yasir S Elhassan; Jan Idkowiak; Karen Smith; Miriam Asia; Helena Gleeson; Rachel Webster; Wiebke Arlt; Michael W O'Reilly
Journal:  J Clin Endocrinol Metab       Date:  2018-03-01       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.